Literature DB >> 32306241

Other types of diffuse liver disease: is there a way to do it?

Hilton Leao Filho1,2, Camila Vilela de Oliveira3, Natally Horvat4,3.   

Abstract

There are a variety of less common diffuse liver diseases that can be asymptomatic or cause severe liver dysfunction. For the majority of them, the association of clinical, laboratory, and imaging findings are needed to narrow the differential diagnosis. In this article, we will review and describe the rarer diffuse liver diseases including drug-related liver disease, inflammatory and infectious diseases, and deposition disorders such as amyloidosis, glycogen storage disease, Wilson's disease, and alpha-1 antitrypsin deficiency. Abdominal radiologists should be familiar with the imaging features of different types of diffuse liver diseases to help the multidisciplinary team involved in the treatment of these patients. The data related to some of these conditions are scarce and sometimes experimental, but we want to demonstrate to the reader the value of imaging techniques in their analysis and introduce the potential of new imaging methods.

Entities:  

Keywords:  Drug toxicity; Infections; Liver diseases; Liver storage diseases

Mesh:

Year:  2020        PMID: 32306241     DOI: 10.1007/s00261-020-02530-6

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  104 in total

1.  Specific vascular complications of orthotopic liver transplantation with preservation of the retrohepatic vena cava: review of 1361 cases.

Authors:  F Navarro; M C Le Moine; J M Fabre; J Belghiti; D Cherqui; R Adam; F R Pruvot; C Letoublon; J Domergue
Journal:  Transplantation       Date:  1999-09-15       Impact factor: 4.939

Review 2.  Drug-related hepatotoxicity.

Authors:  Victor J Navarro; John R Senior
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

3.  Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.

Authors:  Felix G Fernandez; John Ritter; J Wendell Goodwin; David C Linehan; William G Hawkins; Steven M Strasberg
Journal:  J Am Coll Surg       Date:  2005-06       Impact factor: 6.113

Review 4.  Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.

Authors:  F Alessandrino; S H Tirumani; K M Krajewski; A B Shinagare; J P Jagannathan; N H Ramaiya; D N Di Salvo
Journal:  Clin Radiol       Date:  2017-05-02       Impact factor: 2.350

Review 5.  Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?

Authors:  Ahmed Ba-Ssalamah; Nina Bastati; Andreas Wibmer; Romana Fragner; Jacqueline C Hodge; Michael Trauner; Christian J Herold; Mustafa R Bashir; Bernard E Van Beers
Journal:  J Magn Reson Imaging       Date:  2016-11-08       Impact factor: 4.813

Review 6.  CT and MR imaging of chemotherapy-induced hepatopathy.

Authors:  Federica Vernuccio; Marco Dioguardi Burgio; Filippo Barbiera; Silvestro Cusmà; Giuseppe Badalamenti; Massimo Midiri; Valérie Vilgrain; Giuseppe Brancatelli
Journal:  Abdom Radiol (NY)       Date:  2019-10

7.  Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?

Authors:  Nina Bastati; Lucian Beer; Mattias Mandorfer; Sarah Poetter-Lang; Dietmar Tamandl; Yesim Bican; Michael Christoph Elmer; Henrik Einspieler; Georg Semmler; Benedikt Simbrunner; Michael Weber; Jacqueline C Hodge; Federica Vernuccio; Claude Sirlin; Thomas Reiberger; Ahmed Ba-Ssalamah
Journal:  Radiology       Date:  2019-11-19       Impact factor: 11.105

8.  Chemotherapy induced liver abnormalities: an imaging perspective.

Authors:  Ankush Sharma; Roozbeh Houshyar; Priya Bhosale; Joon-Il Choi; Rajesh Gulati; Chandana Lall
Journal:  Clin Mol Hepatol       Date:  2014-09

9.  Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases.

Authors:  Lucian Beer; Mattias Mandorfer; Nina Bastati; Sarah Poetter-Lang; Dietmar Tamandl; Dilyana Plamenova Stoyanova; Michael Christoph Elmer; Georg Semmler; Benedikt Simbrunner; Jacqueline C Hodge; Claude B Sirlin; Thomas Reiberger; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2019-04-18       Impact factor: 5.315

10.  Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.

Authors:  Danny Ngo; Jemianne Bautista Jia; Christopher S Green; Anjalie T Gulati; Chandana Lall
Journal:  Insights Imaging       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.